According to a review study,(34) renin-angiotensin system blockers, especially angiotensin converting enzyme inhibitor inhibitors, may effectively reduce the risk of cardiovascular ischemic events in patients with PAD. This evidence concerns the gene ACE and peripheral arterial disease.